Contact
William H. Frishman, M.D., is an internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology, and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews, and book chapters. He has also edited, co-edited, authored, and co-authored twelve full-length textbooks, including the major text Cardiovascular Pharmacotherapeutics (McGraw-Hill), now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.
Education
- M.D., Boston University School of Medicine
Areas of Expertise
- Cardiovascular Pharmacology
- Clinical Epidemiology
- Geriatrics
Honors and Awards
- Teaching Scholar Award of the American Heart Association
- Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
- Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society
Research
Dr. Frishman has served as a principal investigator in multiple NIH-funded studies, including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Women's Health Initiative Trial" (WHI), and the "Bronx Longitudinal Aging Study."
Publications
- Maheta D, Shah VS, Agrawal SP, et. al. "Beta-Blocker Use in Post-Myocardial Infarction Patients With Preserved Ejection Fraction: A Review." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001066
- Tran HH, Thu A, Twayana AR, et. al. "Are We Monitoring Too Much? A Critical Review of Telemetry Overuse in Inpatient Medicine." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001067
- Whitford T, Frishman WH. "A Review of Venous Thromboembolism Risk, Assessment, and Prophylaxis in Aesthetic Plastic Surgery." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001063
- Ahmad R, Frishman WH, Aronow WS, et. al. "Polycystic Ovary Syndrome and Cardiovascular Disease: Pathophysiology, Clinical Evidence, and Preventive Strategies." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001054
- Agrawal SP, Maheta D, Shah RS, et. al. "When Less Is Not More: Exploring the Current Evidence, Practices, and Perspectives on Fluid Restriction in Patients with Heart Failure." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001059
- Agrawal SP, Maheta D, Rajput J, et. al. "Marijuana and Peripheral Vascular Disease: Pathophysiology, Clinical Evidence, and Cardiovascular Implications." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001065
- Sharma VA, Frishman WH. "Copper Dysregulation and Cardiovascular Disease: A Review of Underlying Mechanisms and Therapeutic Targets." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001051
